PainReform Ltd logo

PainReform Ltd

1
1
NEW
NAS:PRFX (Israel)   Ordinary Shares
$ 2.3 +0.060 (+2.68%) 11:08 PM EST
At Loss
Enterprise V:
$ -764.00K
Volume:
8.02K
Avg Vol (2M):
1.14M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
8.02K
At Loss
Avg Vol (2M):
1.14M

Business Description

PainReform Ltd logo
PainReform Ltd
NAICS : 541714 SIC : 2834
ISIN : IL0011651580

Share Class Description:

PRFX: Ordinary Shares
Description
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Name Current Vs Industry Vs History
Cash-To-Debt 47.17
Equity-to-Asset -0.66
Debt-to-Equity -0.03
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.61
Quick Ratio 0.61
Cash Ratio 0.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26
Name Current Vs Industry Vs History
ROE % -389.96
ROA % -234.96
ROIC % -1724.99
3-Year ROIIC % 1297.8
ROC (Joel Greenblatt) % -3295.01
ROCE % -358.47

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 0.04
EV-to-EBITDA 0.04
EV-to-FCF 0.07
Earnings Yield (Greenblatt) % 2500
FCF Yield % -565.33

Financials (Next Earnings Date:2025-05-15 Est.)

PRFX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PRFX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

PainReform Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -188.359
Beta 0.79
3-Year Sharpe Ratio -1.28
3-Year Sortino Ratio -1.39
Volatility % 97
14-Day RSI 36.19
14-Day ATR ($) 0.226811
20-Day SMA ($) 2.6565
12-1 Month Momentum % -92.41
52-Week Range ($) 1.7272 - 61.199999
Shares Outstanding (Mil) 0.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PainReform Ltd Filings

Filing Date Document Date Form
No Filing Data

PainReform Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

PainReform Ltd Frequently Asked Questions

What is PainReform Ltd(PRFX)'s stock price today?
The current price of PRFX is $2.30. The 52 week high of PRFX is $61.20 and 52 week low is $1.73.
When is next earnings date of PainReform Ltd(PRFX)?
The next earnings date of PainReform Ltd(PRFX) is 2025-05-15 Est..
Does PainReform Ltd(PRFX) pay dividends? If so, how much?
PainReform Ltd(PRFX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1